<DOC>
	<DOCNO>NCT03003715</DOCNO>
	<brief_summary>The main goal study integrate technique produce image brain ( also call neuroimaging technique ) non-invasive brain stimulation investigate factor may associate chronic pain patient Trigeminal Neuropathic Pain ( TNP ) .</brief_summary>
	<brief_title>Brain Therapeutic Research Target Trigeminal Neuropathic Pain</brief_title>
	<detailed_description>Trigeminal neuropathic pain ( TNP ) disorder , classical trigeminal post-surgical neuralgia , debilitate chronic condition pain either spontaneous intensely evoke light touch facial skin . Although neuroimaging technique provide insight brain mechanism experimental trigeminal pain human ( DaSilva et al. , 2002 ; Borsook et al. , 2003 ) , well understood structural molecular mechanism affect course TNP , safely modulate therapeutic research purpose . Understanding process crucial determine structure engage development persistence TNP . We test hypothesis chronicity TNP sustain change cellular molecular level neural circuit associate pain perception modulation , rather initial peripheral etiology , dysfunction safely target modulate therapeutic approach transcranial direct current stimulation ( tDCS ) . To achieve goal use neuroimaging technique , PET , employ mathematical model permit quantification opioid receptor availability vivo .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<criteria>Patient Daily chronic TNP least 6 month adequately control pervious medicine therapy ; minimal average baseline pain score 4 ( moderate severe ) visual analogue scale ( VAS ) ; unilateral pain orofacial allodynic region mechanical ( light touch palpation ) thermal stimulation ( head cold ) ; Patient pregnancy plan become pregnant local pathology ( e.g . orofacial lesion ) history systemic disorder ( e.g . MS ) history chronic pain disorder ( e.g . back pain ) recent orofacial surgery trauma ( &lt; 6 month ) history central origin disorder ( e.g . stroke )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>